Abstract
Purpose
To prospectively evaluate radiation-induced fatigue among patients undergoing curative radiotherapy at the Toronto Sunnybrook Regional Cancer Centre using two different instruments.
Materials and methods
Consecutive consenting English speaking men receiving curative radiotherapy for localised prostate cancer were enrolled in a prospective ethics board approved study. We used an 11 questions fatigue questionnaire (FQ) based on a modified FACT-AN questionnaire and the 2 questions of the fatigue pictogram (FP) to record patients’ responses weekly during treatment. The 11 FQ items were summed to calculate a fatigue scale (FS). The proportion and 95% confidence interval for each FQ and FP item and mean FS was calculated at baseline, week 3 and week 6. Chi-squared tests or analysis of variance f-tests were used to compare treatment groups and paired t-tests to compare baseline to week 6. A linear mixed model was used to compare the mean FS for treatment groups across time.
Results
From June 2000 to June 2003, we enrolled 130 patients. Fifty-one received conformal radiotherapy to the prostate (CRT), 46 received whole pelvis and prostate boost radiotherapy (WP+PB) and 33 received post prostatectomy radiotherapy to the prostate bed (PBRT). At baseline, 39% (30–47%) reported some fatigue for the FQ and 60% (52–68%) for the FP tiredness item. As treatment progressed, the mean fatigue increased significantly. The FP tiredness item best differentiated between treatment groups (p = 0.04 at week 6) compared to the FQ tiredness item or FS. Those receiving irradiation to smaller volumes (CRT or PBRT) reported lower FS scores than those treated to larger volumes (WP+PB) across time.
Conclusions
The pictogram was better than the questionnaire in differentiating between treatment groups. The pictogram could be used to screen and monitor patients with baseline fatigue for interventional studies in a busy clinic.
This is a preview of subscription content,
to check access.

References
Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4–12
Akechi T, Kugaya A, Okamura H, Yamawaki S, Uchitomi Y (1999) Fatigue and its associated factors in ambulatory cancer patients: a preliminary study. J Pain Symptom Manage 17(1):42–48
Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W (1998) Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 12(11A):369–377
Lilleby W, Fossa SD, Waehre HR, Olsen DR (1999) Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 43(4):735–743
Janda M, Gerstner N, Obermair A, Fuerst A, Wachter S, Dieckmann K, Potter R (2000) Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 89(6):1322–1328
Stone P, Richards M, A’Hern R, Hardy J (2001) Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage 22(6):1007–1015
Monga U, Kerrigan AJ, Thornby J, Monga TN (1999) Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig 7(3):178–185
Monga U, Kerrigan AJ, Thornby J, Monga TN, Zimmermann KP (2005) Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy. J Rehabil Res Dev 42(3):391–399
Truong PT, Berthelet E, Lee JC, Petersen R, Lim JTW, Gaul CA, Pai H, Blood P, Ludgate CM (2006) Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy. Can J Urol 13(3):3139–3146
Canadian Cancer Society statistics (2006) http://cancer.ca/ccs/internet/standard/0,2283,3172_14471__langId-en,00.html
Lukka H, Warde P, Pickles T, Morton G, Brundage M, Souhami L; Canadian GU Radiation Oncologist Group (2001) Controversies in prostate cancer radiotherapy: consensus development. Can J Urol 8(4):1314–1322
Lukka H (2002) Prostate cancer: risk categories and role of hormones and radiotherapy. Can J Urol 9(Suppl 1):26–29
Smets EM, Garssen B, Bonke B, De Haes JC (1995) The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315–325
Glaus A (1998) Fatigue in patients with cancer. Analysis and assessment. Recent Results Cancer Res 145(I–XI):1–172
Cella D (1997) The functional assessment of cancer therapy-anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl):13–19
Schwartz AL (1998) The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum 5(4):711–717
Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684
Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP (1993) Development of fatigue scale. J Psychosom Res 37(2):147–153
Glaus A (1993) Assessment of fatigue in cancer and non-cancer patients and in healthy individuals. Support Care Cancer 1(6):285–286
Fitch MI, Bunston T, Mings D, Sevean P, Bakker D (2003) Evaluating a new clinical assessment tool: the fatigue pictogram. Support Care Cancer 11(6):403
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13(2):63–74
Hickok JT, Roscoe JA, Morrow GR, Mustian K, Okunieff P, Bole CW (2005) Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 104(8):1772–1778
Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L (1994) The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17(5):367–378
Monga U, Kerrigan AJ, Thornby J, Monga TN (1999) Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig 7(3):178–185
Greenberg DB, Sawicka J, Eisenthal S, Ross D (1992) Fatigue syndrome due to localized radiation. J Pain Symptom Manage 7(1):38–45
King KB, Nail LM, Kreamer K, Strohl RA, Johnson JE (1985) Patients’ descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum 12(4):55–61
Rodrigues G, Bezjak A, Osoba D, Catton P, Tsuji D, Taylor D, Warde P (2004) The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer. Qual Life Res 13(7):1235–1246
Fitch MI, Bunston T, Mings D (2001) The fatigue pictogram: a new clinical assessment tool. 6th Oncology Nursing Research Conference, Florida, February
Fitch MI Bunston T, Sevean P, Bakker D (2003) Evaluating a new clinical assessment tool: the fatigue pictogram. 15th International Conference of the Multinational Association of Supportive Care in Cancer, Berlin, June
Acknowledgements
We thank Mrs. M. Frost for the secretarial help. We also acknowledge the help of the nurses Jennifer Bates and Ernest Dixon in the radiation review clinic and Edmee Franssen and David Lee for their statistics input.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Danjoux, C., Gardner, S. & Fitch, M. Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer. Support Care Cancer 15, 1169–1176 (2007). https://doi.org/10.1007/s00520-007-0229-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-007-0229-8